{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:15:10Z","timestamp":1761948910483,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E26\/110.426\/2012"],"award-info":[{"award-number":["E26\/110.426\/2012"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oooojournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.oooo.2021.03.011","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T19:24:18Z","timestamp":1616873058000},"page":"320-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunohistochemical analysis of BRCA1 and acetyl-histone H3 in squamous cell carcinoma of the mobile tongue"],"prefix":"10.1016","volume":"132","author":[{"given":"T.C.","family":"Fons\u00eaca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.C.","family":"Abrantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.V.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.A.B.","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Roma\u00f1ach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Agostini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3397-3234","authenticated-orcid":false,"given":"A.C.","family":"Abrah\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2021.03.011_bib0001","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.oooo.2021.03.011_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2019.104551","article-title":"Global patterns and trends in cancers of the lip, tongue and mouth","volume":"102","author":"Miranda-Filho","year":"2020","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oooo.2021.03.011_bib0003","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.oooo.2021.03.011_bib0004","unstructured":"Brazil, Instituto Nacional de C\u00e2ncer Jos\u00e9 de Alencar Gomes da Silva. In: INCA, ed. Estimate\/2020 \u2013 Cancer Incidence in Brazil. Rio de Janeiro: INCA; 2019. https:\/\/www.inca.gov.br\/estimativa, Accessed 01 november 2020."},{"key":"10.1016\/j.oooo.2021.03.011_bib0005","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cncr.23183","article-title":"Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma","volume":"112","author":"Rusthoven","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.oooo.2021.03.011_bib0006","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00428-017-2212-1","article-title":"Evaluation of the budding and depth of invasion (BD) model in oral tongue cancer biopsies","volume":"472","author":"Almangush","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.oooo.2021.03.011_bib0007","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4252\/wjsc.v6.i5.511","article-title":"Histone modifications: targeting head and neck cancer stem cells","volume":"6","author":"Le","year":"2014","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.oooo.2021.03.011_bib0008","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/onc.2011.237","article-title":"Regulation of the activation of the Fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitor","volume":"31","author":"Rego","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.oooo.2021.03.011_bib0009","doi-asserted-by":"crossref","first-page":"383","DOI":"10.18632\/oncoscience.47","article-title":"BRCA1 and \u03b3H2AX as independent prognostic markers in oral squamous cell carcinoma","volume":"1","author":"Oliveira-Costa","year":"2014","journal-title":"Oncoscience"},{"key":"10.1016\/j.oooo.2021.03.011_bib0010","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jso.10213","article-title":"BRCA1 expression in leukoplakia and carcinoma of the tongue","volume":"83","author":"Vora","year":"2003","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.oooo.2021.03.011_bib0011","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.270.5237.789","article-title":"Aberrant subcellular localization of BRCA1 in breast cancer","volume":"270","author":"Chen","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.oooo.2021.03.011_bib0012","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/1097-0215(20000801)87:3<317::AID-IJC2>3.0.CO;2-B","article-title":"Frequent loss of BRCA1 mrsna and protein expression in sporadic ovarian cancers","volume":"87","author":"Russell","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.oooo.2021.03.011_bib0013","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/his.13218","article-title":"Hypoacetylation of acetyl-histone H3 (H3K9ac) as marker of poor prognosis in oral cancer","volume":"71","author":"Webber","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.oooo.2021.03.011_bib0014","first-page":"390","article-title":"BRCA1\/2 expression patterns in different grades of oral squamous cell carcinoma","volume":"11","author":"Irani","year":"2020","journal-title":"Middle East J Cancer"},{"year":"2017","series-title":"WHO Classification of Head and Neck Tumours","key":"10.1016\/j.oooo.2021.03.011_bib0015"},{"key":"10.1016\/j.oooo.2021.03.011_bib0016","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/bjc.2013.70","article-title":"BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group study","volume":"108","author":"Lesnock","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.oooo.2021.03.011_bib0017","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/dc.20839","article-title":"Comparison of PAX-2, RCC antigen, and antiphosphorylated H2AX antibody (gamma-H2AX) in diagnosing metastatic renal cell carcinoma by fine-needle aspiration","volume":"36","author":"Wasco","year":"2008","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.oooo.2021.03.011_bib0018","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ygyno.2011.08.017","article-title":"BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer","volume":"123","author":"Carser","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.oooo.2021.03.011_bib0019","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/ijgc-00009577-200602001-00026","article-title":"BRCA1 expression in a large series of sporadic ovarian carcinomas: a Gynecologic Oncology Group study","volume":"16","author":"Thrall","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.oooo.2021.03.011_bib0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1365-2559.1999.00578.x","article-title":"Immunolocallization of BRCA1 protein in normal breast tissue and sporadic invasive ductal carcinomas: a correlation with other biological parameters","volume":"34","author":"Lee","year":"1999","journal-title":"Histopathology"},{"key":"10.1016\/j.oooo.2021.03.011_bib0021","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00432-010-0795-x","article-title":"Expression of TRF1, TRF2, TIN2, TERT, KU70, and BRCA1 proteins is associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer","volume":"136","author":"Hu","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.oooo.2021.03.011_bib0022","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/bjc.2015.208","article-title":"Association between cytosolic expression of BRCA1 and metastatic risk in breast cancer","volume":"113","author":"Santivasi","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.oooo.2021.03.011_bib0023","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1158\/1078-0432.CCR-07-1083","article-title":"BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy","volume":"13","author":"Quinn","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.oooo.2021.03.011_bib0024","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2174\/156800909788166592","article-title":"A systematic review of genes\u2014BRCA1 and paclitaxel chemotherapy","volume":"9","author":"Stordal","year":"2009","journal-title":"Current Cancer Drug Targets"},{"key":"10.1016\/j.oooo.2021.03.011_bib0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.oraloncology.2017.05.008","article-title":"A phase I study of cabazitaxel in combination with platinum and 5-fluorouracil (PF) in locally advanced squamous cell carcinoma of head and neck (LA-SCCHN)","volume":"71","author":"Camille","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oooo.2021.03.011_bib0026","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.oraloncology.2019.05.028","article-title":"ATR inhibition sensitizes HPV(\u2212) and HPV(+) head and neck squamous cell carcinoma to cisplatin","volume":"95","author":"Leonard","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oooo.2021.03.011_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104753","article-title":"Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck","volume":"108","author":"Day","year":"2020","journal-title":"Oral Oncol"},{"year":"2010","series-title":"Essential Concepts in Molecular Pathology","author":"Coleman","key":"10.1016\/j.oooo.2021.03.011_bib0028"},{"key":"10.1016\/j.oooo.2021.03.011_bib0029","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.dnarep.2005.06.007","article-title":"Chromatin and the DNA damage response","volume":"4","author":"Lydall","year":"2005","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.oooo.2021.03.011_bib0030","doi-asserted-by":"crossref","first-page":"e58672","DOI":"10.1371\/journal.pone.0058672","article-title":"Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer","volume":"8","author":"Giudice","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.oooo.2021.03.011_bib0031","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1440-1827.2011.02776.x","article-title":"Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients","volume":"62","author":"Song","year":"2012","journal-title":"Pathol Int"},{"key":"10.1016\/j.oooo.2021.03.011_bib0032","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3109\/07357907.2011.597810","article-title":"Abnormal histone acetylation and methylation levels in esophageal squamous cell carcinomas","volume":"29","author":"Chen","year":"2011","journal-title":"Cancer Invest"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440321001619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440321001619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:08:53Z","timestamp":1761948533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440321001619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2212440321001619"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2021.03.011","relation":{},"ISSN":["2212-4403"],"issn-type":[{"type":"print","value":"2212-4403"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunohistochemical analysis of BRCA1 and acetyl-histone H3 in squamous cell carcinoma of the mobile tongue","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2021.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}